SEC filingsOct 12, 2026 to Oct 19, 2026: insiders reported 840 purchases and sales across 212 companies.840 insider purchases and sales in 7 daysSee the filings →
HornScout

Company profile

SKYE

Skye Bioscience Inc.
NASDAQHealth Care

Latest close: 1.55 USD · Oct 16, 2026 · 1 year · split-adjusted

On the price, the facts of the public record■Insider buy□Insider sell◆Adverse 8-K filing◇Significant stake declared (13D)●Results filed
With an account, also○dividends▲splits◌next earningswith an account

End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.

Latest on record

The most recent facts, as filed.

Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.

  1. Sep 23, 2026Reported sale · Form 4Andrew J. Schwab · $184.9KOpen the filing ↗
  2. Sep 23, 2026Reported sale · Form 4Andrew J. Schwab · $7.3KOpen the filing ↗
  3. Sep 22, 2026Reported sale · Form 4Andrew J. Schwab · $1.8KOpen the filing ↗

In numbers

What this profile holds, counted.

Closes · 1 year249
SEC filings on record5688 flagged findings
Reported transactions (Form 4)80since Feb 29, 2024 · and 20 other holdings
Corporate events (8-K)30since Sep 1, 2023

What the record says

Description, identity and filings, each with its source.

Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.

Listing notice in force

The exchange has notified the company that it fails a continued-listing requirement (8-K, item 3.01 of Aug 19, 2026).

  • stockholders' equity · Nasdaq, rule 5450(b)(1)(A) · notice of May 13, 2026 · pending · no automatic period

Open the 8-K at the SEC

Reverse splits in 5 years

2 reverse splits in 5 years (1:250 on Sep 8, 2023, 1:8 on Aug 24, 2026) · 1:2000 cumulative

The other times: of 247 securities that repeated a reverse split in 5 years, a year later the median was worth 0.10× the price on the day of the split; 189 lost more than half and 21 rose (243 with a price a year later).

Our own series, not the whole market: based on the splits we have on record (provider and SEC); an unrecorded one does not count. Historical distribution, not a prediction.

SEC record

SEC dossier

What this company has filed with the SEC, in plain language.

The 25 most recent filings (of 568)

Everything filed

Every SEC filing, newest first, with what it is. Below, each type with its own explanation.

  • Oct 14, 26SCHEDULE 13G ↗Passive stake · TANG CAPITAL MANAGEMENT, LLC · 6.0% · event on Oct 7, 26 new
  • Sep 24, 26SCHEDULE 13D/A ↗Stake with intent to influence · Andrew J. Schwab · 26.1% · event on Sep 22, 26 · amendment
  • Insider transaction · 4 Form 4 filingsshow all 4hide
  • Sep 11, 26DEFA14A ↗Shareholder meeting and votes
  • Sep 11, 268-K ↗Current report · A material agreement was terminated
  • Aug 24, 26DEFA14A ↗Shareholder meeting and votes
  • Aug 24, 268-K ↗Current report · Entered a material agreement
  • Aug 20, 26DEFA14A ↗Shareholder meeting and votes
  • Aug 20, 268-K/A ↗Current report · Change in shareholder rights · amendment
  • Insider transaction · 2 Form 4 filingsshow all 2hide
  • Aug 19, 26DEFA14A ↗Shareholder meeting and votes
  • Aug 19, 268-K ↗Current report · Listing notice (8-K 3.01)
  • Aug 18, 26SCHEDULE 13D/A ↗Stake with intent to influence · Andrew J. Schwab · 30.2% · event on Aug 14, 26 · amendment
  • Aug 14, 26DEFA14A ↗Shareholder meeting and votes
  • Aug 14, 2610-Q ↗Quarterly report
  • Aug 14, 268-K ↗Current report · Sold unregistered shares
  • Aug 7, 26Form 4 ↗Insider transaction
  • Jun 23, 268-K ↗Current report · Other events
  • May 29, 268-K ↗Current report · Bylaws or fiscal year change · Shareholder vote results
  • May 15, 268-K ↗Current report · Listing notice (8-K 3.01)
  • May 11, 2610-Q ↗Quarterly report

568 filings on record, the oldest from Jan 30, 13.

Listing the 25 most recent filings of the 568 on record.

8-Ks, explained

Stress3Structure94Governance48
  • Sep 11, 26StructureA material agreement was terminated+2 more in the same filing8-K 1.02 ↗
  • Aug 24, 26StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Aug 19, 26StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Aug 14, 26StructureSold unregistered shares+7 more in the same filing8-K 3.02 ↗
  • May 15, 26StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Apr 6, 26GovernanceA senior executive left or was appointed8-K/A 5.02 ↗
  • Apr 3, 26GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
  • Mar 19, 26StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Feb 20, 26GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Dec 23, 25StructureEntered a material agreement8-K 1.01 ↗
  • Jun 11, 25GovernanceAuditor change filing (8-K Item 4.01)+2 more in the same filing8-K 4.01 ↗
  • Governance5 senior executive changes2024 – 2025show all 5hide
    • Feb 26, 25GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
    • Oct 29, 24GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
    • Oct 24, 24GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
    • Sep 4, 24GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
    • Jul 3, 24GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗

6 older filings not shown · The record reaches back to Jun 17, 13.

Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.

Ownership and control

Schedule 13D: stake and stated purpose

Filed by holders above 5% of a share class who cannot use the short form. It includes the investor's stated purpose: read it before assuming they seek influence.

  • Andrew J. Schwab26.1%Sep 22, 26SCHEDULE 13D/A ↗9 co-filers on this document — the figure is the largest single stake, not their sum. · 3 earlier filings

Schedule 13G: short-form filing

The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.

  • TANG CAPITAL MANAGEMENT, LLC6.0%Oct 7, 26SCHEDULE 13G ↗6 co-filers on this document — the figure is the largest single stake, not their sum.
  • Sphera Funds Management Ltd.4.8%Mar 31, 25SCHEDULE 13G/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum.
  • Schonfeld Strategic Advisors LLC3.6%Jun 30, 25SCHEDULE 13G/A ↗1 earlier filing

Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.

SEC record

Insider transactions

Buys and sells reported by officers, directors and major shareholders on SEC Form 4.

Buys and sells

  • Sep 23, 26Sell$185KAndrew J. Schwab↗
  • Sep 23, 26Sell$7KAndrew J. Schwab↗
  • Sep 22, 26Sell$2KAndrew J. Schwab↗
  • Sep 22, 26Sell$46KAndrew J. Schwab↗
  • Sep 16, 26Sell$2KAndrew J. Schwab↗
  • Sep 16, 26Sell$62KAndrew J. Schwab↗
  • Aug 20, 26Sell$371Andrew J. Schwab↗
  • Aug 20, 26Sell$15Andrew J. Schwab↗
  • Aug 20, 26Sell$2KAndrew J. Schwab↗
  • Aug 19, 26Sell$4KAndrew J. Schwab↗
  • Aug 19, 26Sell$143Andrew J. Schwab↗
  • Aug 19, 26Sell$20KAndrew J. Schwab↗

There are 22 more transactions in this stretch.

Stock compensation, tax and giftsshow the 6 other transactionshide

Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.

  • Aug 7, 26Compensationamount n/aPUNIT DHILLONChief Executive Officer↗
  • Aug 26, 24Otheramount n/aPUNIT DHILLONChief Executive Officer↗
  • Mar 13, 24Compensation$4.5MAndrew J. Schwab↗
  • Feb 29, 24Compensationamount n/aPUNIT DHILLONChief Executive Officer↗
  • Feb 29, 24Compensationamount n/aKAITLYN ARSENAULTChief Financial Officer↗
  • Feb 29, 24Compensationamount n/aTuan Tu DiepChief Development Officer↗

The full record holds 59 transactions and goes back to Nov 10, 22.

Its sector and its market

Skye Bioscience Inc. among Health Care companies

The profile shows what is on record. Context and Radar place the company among those of its sector and region.

With an account you also get

  • The four engines — growth, trend, risk and context — each with its word and its score.
  • The risk band and the sector phase.
  • The company's fundamentals and accounts.
  • Watchlist: your list of companies, with the «since you follow it» figure.

The research continues

The profile tells the story. The market sets the scene.

From Skye Bioscience Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.

  1. Place it in its market

    Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.

    See how Context works →
  2. See what deserves a closer look

    Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.

    See how Radar works →
  3. Keep the why

    Follow Skye Bioscience Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.

    See an example review →

Coverage

What sits behind this page.

Where each figure comes from and how far it reaches.

Prices
End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
Series quality
249 clean closes in the period.
SEC records
568 documents on file, from Jan 30, 2013 to Oct 14, 2026.
Company description
No description available.
This page
Generated on Oct 19, 2026; refreshed through the day.

Start at your own pace

Explore first. Go deeper with access.

Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.

Compare plans →
  • No account

    This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.

  • Pro

    What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.

  • Pro+

    Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.

Are the prices real time?

No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.

Which SEC documents appear here?

Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.

Why does a European company show no SEC records?

It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.

Before forming a view on a company,
read what is on record.

One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.

Access by invitation while the beta lasts. Not advice: the profile shows what is on record; it does not recommend.

Skye Bioscience Inc. (SKYE): stock price history, insider trades and SEC filings — HornScout